Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma

This study has been terminated.
(Study terminated due to low patient enrollment.)
Sponsor:
Collaborators:
Novartis Pharmaceuticals
Walther Cancer Institute
Information provided by:
Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT00216151
First received: September 12, 2005
Last updated: April 28, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)